Frazier Life Sciences Management, L.P.: summary

Frazier Life Sciences Management, L.P. reported 41 positions with a reported value of $4.59B in its 13F for Q2 2026. Compared with Q1 2026: 6 new positions, 3 exited.

Top positions

• Mirum Pharmaceuticals Inc
• NEWAMSTERDAM PHARMA COMPANY
• Erasca Inc
• MBX Biosciences Inc
• Arcutis Biotherapeutics Inc
• Trevi Therapeutics Inc
• Krystal Biotech Inc
• Maze Therapeutics Inc
• Phathom Pharmaceuticals Inc
• Palvella Therapeutics Inc